Hirofumi Yamamoto

7PUBLICATIONS
20CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 04, 2026
miR-136-5p Preferentially Suppresses Cancer Stem-like Cells in Pancreatic Cancer.

|Dec 11, 2025
MicroRNA-1 Suppresses Tumor Progression and UHRF1 Expression in Cholangiocarcinoma.

Makoto Muto, Teruhide Ishigame, Takashi Kimura

|Jan 11, 2025
The Efficacy of FOLFIRI Plus Ramucirumab in Recurrent Colorectal Cancer Refractory to Adjuvant Chemotherapy with Oxaliplatin/Fluoropyrimidine-Including Biomarker Analyses.

Naotoshi Sugimoto, Shingo Noura, Takeshi Kato

|May 08, 2023
Long noncoding RNA 01534 maintains cancer stemness by downregulating endoplasmic reticulum stress response in colorectal cancer.

Momoko Ichihara, Hidekazu Takahashi, Naohiro Nishida

|Jul 18, 2022
Micrometastasis in lymph nodes of colorectal cancer.

Hirofumi Yamamoto

|Jun 07, 2021
Validation of the conventional Glasgow Prognostic Score and development of the improved Glasgow Prognostic Score in patients with stage 0-III colorectal cancer after curative resection.

Satoshi Ishikawa, Norikatsu Miyoshi, Shiki Fujino

Pageof 2

Frequent Collaborators

2 joint publications

Norikatsu Miyoshi

2 joint publications

Hidekazu Takahashi

2 joint publications

Mamoru Uemura

2 joint publications

Hidetoshi Eguchi